KM Research Hub
← 返回论文库
无 KM 图 入排:符合 图源:开放图源暂不可得 入排置信度 0.98

Peripheral blood cells as prognostic markers in patients with advanced non-small cell lung cancer treated with cemiplimab as monotherapy or in combination with chemotherapy.

Rolando J Acosta, Debra A G McIntyre, Joseph C Murray, Valsamo Anagnostou, Julie R Brahmer, Alexander Meisel, Ahmet Sezer, Miranda Gogishvili, Tamar Melkadze, Ana Baramidze, Tamta Makharadze, Adam Y He, Vladimir Jankovic, Gregory P Geba, Asha Pillai, Frank Seebach, Petra Rietschel, Giuseppe Gullo, Jean-Francois Pouliot, Young Kim

Cancer Treat Res Commun 44 100959

PMID40700835
PMCID-
DOI10.1016/j.ctarc.2025.100959
发表日期2025-07-23
入排依据:原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。
图像/No. at risk 复核:未获得 PubMed/PMC 可审查 Figure,无法核实 KM 曲线与 No. at risk 表。
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。
摘要

摘要

BACKGROUND: Patients with a high neutrophil/lymphocyte ratio (NLR) have poor prognosis in non-small cell lung cancer (NSCLC). Limited data are available on the contribution of other immune cells. This analysis assessed the prognostic importance of NLR and other peripheral blood cells in patients with advanced NSCLC receiving the PD-1 inhibitor cemiplimab in 2 large phase III studies. METHODS: The impact of baseline immune cells on survival was assessed in patients with complete blood cell counts. Cox proportional hazard regression and Kaplan-Meier methods assessed the relationships between baseline blood cell counts and survival. Data were randomly split into training (70 %) and validation (30 %) cohorts to allow for independent evaluation of the Cox model. RESULTS: Multivariable analyses revealed that a higher NLR (HR: 1.09; 95 % CI: 1.06-1.12, P < .001) and monocytes (HR: 1.49; 95 % CI: 1.15-1.93, P < .001) were strongly associated with an increased risk of death. Higher levels of eosinophils (HR: 0.93; 95 % CI: 0.88-0.99, P < .001) were associated with a reduced risk of death. A calibration curve of observed and predicted probabilities in the unseen test set using independent data revealed that the Cox model was well-calibrated up to a 1-year mortality probability of approximately 30 %. Harrell's concordance index was 0.61, indicating a modest predictive performance. CONCLUSIONS: Our data confirmed the detrimental impact of a high NLR on survival and revealed the importance of monocyte levels in anti-tumor responses, providing useful information to physicians treating advanced NSCLC that may help tailor immunotherapy regimens and provide more accurate prognostic assessments.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。